Common use of Biological Samples Clause in Contracts

Biological Samples. If so specified in the Protocol and the informed consent document, Principal Investigator may collect and provide to CRO, Pfizer or their designee biological samples obtained from Study Subjects (e.g., blood, urine, tissue, saliva, etc) for testing that is not directly related to Study Subject care or safety monitoring, such as pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). Biological Samples may include Personal Data of Study Subjects. 11.2

Biological Samples. If so specified in the Protocol and the informed consent document, Principal Investigator may collect and provide to CRO, Pfizer or their designee biological samples obtained from Study Subjects (e.g., blood, urine, tissue, saliva, etc) for testing that is not directly related to Study Subject care or safety monitoring, such as pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). Biological Samples may include Personal Data of Study Subjects. 11.2

Biological Samples. If so specified in the Protocol and the informed consent document, Principal Investigator may collect and provide to CRO, Pfizer or their designee biological samples obtained from Study Subjects (e.g., blood, urine, tissue, saliva, etc) for testing that is not directly related to Study Subject care or safety monitoring, such as pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). Biological Samples may include Personal Data of Study Subjects. 11.2a.

Biological Samples. If so specified in the Protocol and the informed consent documentdocument , Principal Investigator may collect and provide to CRO, Pfizer SPONSOR or their SPONSOR’s designee the biological samples obtained from Study Subjects (e.g., blood, urine, tissue, saliva, etc.) obtained from Study Subjects for testing that is not directly related to Study Subject subject care or safety monitoring, such as pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). Biological Samples may include Personal Data of Study Subjects. 11.2.

Biological Samples. If so specified in the Protocol and the informed consent document, Principal Investigator may collect and provide to CRO or CRO, Pfizer or their ’s designee biological samples obtained from Study Subjects (e.g., blood, urine, tissue, saliva, etc) for testing that is not directly related to Study Subject care or safety monitoring, such as pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). Biological Samples may include Personal Data of Study Subjects. 11.2.

Biological Samples. If so specified in the Protocol and the informed consent document, Principal Investigator may collect and provide to CRO, Pfizer or their designee biological samples obtained from Study Subjects (e.g., blood, urine, tissue, saliva, etc) for testing that is not directly related to Study Subject care or safety monitoring, such as pharmacokineticúčastníkov alebo sledovaním bezpečnosti, pharmacogenomicako sú farmakokinetické, or biomarker testing farmakogenomické testy alebo testovanie iných biomarkerov (“Biological Samplesďalej „biologické vzorky”). Biological Samples may include Personal Data of Study Subjects. 11.2Biologické vzorky môžu obsahovať osobné údaje účastníkov klinického skúšania.

Biological Samples. If so specified in the Protocol and the informed consent document, Principal Investigator may collect and provide to CRO, Pfizer Sponsor or their designee designee, biological samples obtained from Study Subjects trial subjects (e.g., blood, urine, tissue, saliva, etc) for testing that is not directly related to Study Subject trial subject care or safety monitoring, such as pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). Biological Samples may include Personal Data (as defined below) of Study Subjects. 11.2trial subjects.

Biological Samples. If so specified in the Protocol and the informed consent document, Principal Investigator may collect and provide to CRO, Pfizer or their designee biological samples obtained from Study Subjects (e.g., blood, urine, tissue, saliva, etc) for testing that is not directly related to Study Subject care or safety monitoring, such as pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). Biological Samples may include Personal Data of Study Subjects. 11.2.

Biological Samples. If so specified in the Protocol and the informed consent document, Principal Investigator may collect and provide to CRO, Pfizer or their designee biological samples obtained from Study Subjects (e.g., blood, urine, tissue, saliva, etc) for testing that is not directly related to Study Subject care or safety monitoring, such as pharmacokinetic, pharmacogenomic, or biomarker testing (“Biological Samples”). Biological Samples may include Personal Data of Study Subjects. 11.2safety